Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Roth Capital cut their Q2 2025 EPS estimates for shares of Celsius in a research report issued on Thursday, May 29th. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.17 per share for the quarter, down from their previous estimate of $0.24. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q4 2025 earnings at $0.20 EPS, Q3 2026 earnings at $0.28 EPS, Q4 2026 earnings at $0.33 EPS and FY2027 earnings at $1.38 EPS.
CELH has been the subject of several other research reports. Roth Mkm reiterated a "buy" rating and issued a $38.00 price target on shares of Celsius in a research report on Friday, February 21st. Needham & Company LLC reiterated a "buy" rating and issued a $47.00 price target on shares of Celsius in a research report on Thursday. LADENBURG THALM/SH SH reduced their price target on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Piper Sandler upped their price target on shares of Celsius from $43.00 to $44.00 and gave the company an "overweight" rating in a research report on Thursday, April 17th. Finally, JPMorgan Chase & Co. upped their price target on shares of Celsius from $39.00 to $44.00 and gave the company an "overweight" rating in a research report on Friday, May 2nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $47.00.
Check Out Our Latest Analysis on CELH
Celsius Price Performance
Shares of NASDAQ:CELH traded up $0.22 during trading on Monday, hitting $38.10. 6,635,097 shares of the company were exchanged, compared to its average volume of 8,029,733. The firm's 50 day moving average price is $36.34 and its 200-day moving average price is $30.44. Celsius has a 12-month low of $21.10 and a 12-month high of $79.52. The stock has a market capitalization of $9.82 billion, a P/E ratio of 86.59, a PEG ratio of 2.90 and a beta of 1.65.
Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million for the quarter, compared to analysts' expectations of $349.09 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm's quarterly revenue was down 7.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.27 EPS.
Insider Activity
In other news, Director Joyce Russell sold 4,000 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the transaction, the director now owns 19,106 shares in the company, valued at $543,947.82. This trade represents a 17.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the transaction, the insider now owns 45,297 shares of the company's stock, valued at $1,167,303.69. This represents a 18.36% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.55% of the company's stock.
Hedge Funds Weigh In On Celsius
Large investors have recently made changes to their positions in the stock. HM Payson & Co. increased its holdings in shares of Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock valued at $26,000 after purchasing an additional 550 shares in the last quarter. Westside Investment Management Inc. acquired a new stake in Celsius in the 1st quarter valued at about $32,000. Summit Securities Group LLC acquired a new stake in Celsius in the 1st quarter valued at about $34,000. S.A. Mason LLC grew its stake in Celsius by 100.0% in the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock valued at $37,000 after acquiring an additional 700 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its stake in Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after acquiring an additional 750 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.
About Celsius
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.